These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10638395)

  • 21. Low frequency of defective alleles of cytochrome P450 enzymes 2C19 and 2D6 in the Turkish population.
    Aynacioglu AS; Sachse C; Bozkurt A; Kortunay S; Nacak M; Schröder T; Kayaalp SO; Roots I; Brockmöller J
    Clin Pharmacol Ther; 1999 Aug; 66(2):185-92. PubMed ID: 10460072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CYP2D6 genotype and phenotype relationship in South Indians.
    Naveen AT; Prasanna T; Farzana BL; Rajan S; Adithan C
    J Postgrad Med; 2006; 52(4):253-6. PubMed ID: 17102541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid and comprehensive determination of cytochrome P450 CYP2D6 poor metabolizer genotypes by multiplex polymerase chain reaction.
    Roberts R; Joyce P; Kennedy MA
    Hum Mutat; 2000; 16(1):77-85. PubMed ID: 10874309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Limited effects of frequent CYP2D6*36-*10 tandem duplication allele on in vivo dextromethorphan metabolism in a Japanese population.
    Kiyotani K; Shimizu M; Kumai T; Kamataki T; Kobayashi S; Yamazaki H
    Eur J Clin Pharmacol; 2010 Oct; 66(10):1065-8. PubMed ID: 20700584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytochrome P450 II D6 gene polymorphisms and the neuroleptic-induced extrapyramidal symptoms in Japanese schizophrenic patients.
    Inada T; Senoo H; Iijima Y; Yamauchi T; Yagi G
    Psychiatr Genet; 2003 Sep; 13(3):163-8. PubMed ID: 12960748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CYP2D6 and CYP2C19 activity in a large population of Dutch healthy volunteers: indications for oral contraceptive-related gender differences.
    Tamminga WJ; Wemer J; Oosterhuis B; Weiling J; Wilffert B; de Leij LF; de Zeeuw RA; Jonkman JH
    Eur J Clin Pharmacol; 1999 May; 55(3):177-84. PubMed ID: 10379632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of the nonfunctional CYP2D6 31 allele in Spanish, Puerto Rican, and US Hispanic populations.
    Gaedigk A; Isidoro-García M; Pearce RE; Sánchez S; García-Solaesa V; Lorenzo-Romo C; Gonzalez-Tejera G; Corey S
    Eur J Clin Pharmacol; 2010 Sep; 66(9):859-64. PubMed ID: 20473659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic polymorphism in cytochrome P450 2D6 (CYP2D6): Population distribution of CYP2D6 activity.
    Neafsey P; Ginsberg G; Hattis D; Sonawane B
    J Toxicol Environ Health B Crit Rev; 2009; 12(5-6):334-61. PubMed ID: 20183526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The CYP2D6 activity score: translating genotype information into a qualitative measure of phenotype.
    Gaedigk A; Simon SD; Pearce RE; Bradford LD; Kennedy MJ; Leeder JS
    Clin Pharmacol Ther; 2008 Feb; 83(2):234-42. PubMed ID: 17971818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacogenetic comparison of CYP2D6 predictive and measured phenotypes in a South African cohort.
    Dodgen TM; Labuschagne CJ; van Schalkwyk A; Steffens FE; Gaedigk A; Cromarty AD; Alessandrini M; Pepper MS
    Pharmacogenomics J; 2016 Nov; 16(6):566-572. PubMed ID: 26503815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CYP2D6 polymorphism in a Gabonese population: contribution of the CYP2D6*2 and CYP2D6*17 alleles to the high prevalence of the intermediate metabolic phenotype.
    Panserat S; Sica L; Gérard N; Mathieu H; Jacqz-Aigrain E; Krishnamoorthy R
    Br J Clin Pharmacol; 1999 Jan; 47(1):121-4. PubMed ID: 10073750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of CYP2D6 polymorphisms on neuroleptic malignant syndrome.
    Kato D; Kawanishi C; Kishida I; Furuno T; Suzuki K; Onishi H; Hirayasu Y
    Eur J Clin Pharmacol; 2007 Nov; 63(11):991-6. PubMed ID: 17701031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risperidone plasma levels, clinical response and side-effects.
    Riedel M; Schwarz MJ; Strassnig M; Spellmann I; Müller-Arends A; Weber K; Zach J; Müller N; Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 2005 Aug; 255(4):261-8. PubMed ID: 15565299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic polymorphism of CYP2D6 and CYP2C19 metabolism determined by phenotyping Israeli ethnic groups.
    Britzi M; Bialer M; Arcavi L; Shachbari A; Kapitulnik T; Soback S
    Ther Drug Monit; 2000 Oct; 22(5):510-6. PubMed ID: 11034254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of the CYP2D6 polymorphism on psychopathological and extrapyramidal symptoms in the patients on long-term antipsychotic treatment.
    Plesnicar BK; Zalar B; Breskvar K; Dolzan V
    J Psychopharmacol; 2006 Nov; 20(6):829-33. PubMed ID: 16478753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The African-specific CYP2D617 allele encodes an enzyme with changed substrate specificity.
    Wennerholm A; Dandara C; Sayi J; Svensson JO; Abdi YA; Ingelman-Sundberg M; Bertilsson L; Hasler J; Gustafsson LL
    Clin Pharmacol Ther; 2002 Jan; 71(1):77-88. PubMed ID: 11823760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CYP2D6 genotype and phenotype determination in a Mexican Mestizo population.
    López M; Guerrero J; Jung-Cook H; Alonso ME
    Eur J Clin Pharmacol; 2005 Nov; 61(10):749-54. PubMed ID: 16249913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of the CYP2D6 genotype on metoprolol metabolism persists during long-term treatment.
    Rau T; Heide R; Bergmann K; Wuttke H; Werner U; Feifel N; Eschenhagen T
    Pharmacogenetics; 2002 Aug; 12(6):465-72. PubMed ID: 12172215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CYP2D6 phenotype prediction from genotype: which system is the best?
    Kirchheiner J
    Clin Pharmacol Ther; 2008 Feb; 83(2):225-7. PubMed ID: 18202689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CYP2D6 mutations and therapeutic outcome in schizophrenic patients.
    Hamelin BA; Dorson PG; Pabis D; Still D; Bouchard RH; Pourcher E; Rail J; Turgeon J; Crismon ML
    Pharmacotherapy; 1999 Sep; 19(9):1057-63. PubMed ID: 10610012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.